China Cord Blood Corporation operates within the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Cord Blood with three other
health care providers in Asia:
Cordlife Group Limited
sales of 59.63 million Singapore Dollars [US$41.70 million]
of which 99%
MediNet Group Ltd
of Hong Kong
(92.58 million Hong Kong Dollars [US$11.94 million]
Human Health Holdings Ltd
based in Hong Kong
(480.26 million Hong Kong Dollars [US$61.92 million]
of which 70%
was General practice services).
During the year ended March of 2016, sales at
China Cord Blood were 663.00 million Chinese Renmimbi (US$96.94 million).
increase of 4.4%
versus 2015, when the company's sales were 635.12 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China Cord Blood
(and since 2011, sales have increased a total of 95%).